{"id":4184,"date":"2023-07-04T00:54:12","date_gmt":"2023-07-03T22:54:12","guid":{"rendered":"https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/"},"modified":"2024-11-29T18:12:31","modified_gmt":"2024-11-29T17:12:31","slug":"why-shares-of-ventyx-biosciences-rose-monday","status":"publish","type":"post","link":"https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/","title":{"rendered":"Why Shares of Ventyx Biosciences Rose Monday"},"content":{"rendered":"\n<h2>What took place<\/h2>\n<p>On Monday, shares of <strong><a href=\"https:\/\/oxfordwisefinance.com\/blog\/2-market-beating-stocks-with-more-upside-potential\/\">Ventyx Biosciences<\/a><\/strong> <span class=\"ticker\" data-id=\"379638\">(NASDAQ: VTYX)<\/span> closed 22.87% greater than they did recently. The clinical-stage biotech hit more than $40 a share for the very first time because March 10.<\/p>\n<h2>So what<\/h2>\n<p>Ventyx concentrates on treatments to deal with inflammatory illness and autoimmune conditions. The business has 4 programs in its pipeline, consisting of 2 in stage 2 trials:<\/p>\n<ul>\n<li>VTX958, an allosteric TYK2 inhibitor to deal with plaque psoriasis, Crohn&#8217;s illness, psoriatic arthritis<em>,<\/em> and other autoimmune illness, and<\/li>\n<li>VTX002, a S1P1 receptor modulator for the treatment of ulcerative colitis.<\/li>\n<\/ul>\n<p>Investors searching for ideas about how the <a href=\"https:\/\/oxfordwisefinance.com\/blog\/when-do-student-loans-program-up-on-your-credit-report\/\">programs are going got thrilled Monday although the business reported<\/a> through its Securities and Exchange Commission filings that a number of experts were dumping business stock.<\/p>\n<p>Normally, that&#8217;s viewed as an unfavorable indication, however experts cost a range of factors, and other aspects are at work to increase the stock. Clinical-phase biotechs with autoimmune treatments have actually been hot tickets recently. <strong>Prometheus Biosciences<\/strong> was just recently obtained by <strong><a href=\"https:\/\/oxfordwisefinance.com\/blog\/octobers-worst-performing-dow-jones-stocks-buy-now\/\">Merck<\/a><\/strong>, with the offer closing on June 16, and <strong>Dice Therapeutics<\/strong> was purchased by <strong>Eli Lilly<\/strong> in an arrangement that was revealed on June 20.<\/p>\n<h2>Now what<\/h2>\n<p>With little news to go on, it makes good sense for many financiers to remain clear of Ventyx in the meantime. While it has some appealing treatments, it had just $376.9 million in <a href=\"https:\/\/oxfordwisefinance.com\/blog\/money-tree-hours-of-operation\/\">money since the very first quarter &#8212; enough, it stated, to money operations<\/a> into 2025. One thing that bears seeing is the top-line readout of VTX958&#8217;s stage 2 trial, anticipated later on this year.<\/p>\n<p><strong>10 stocks we like much better than Ventyx Biosciences<\/strong><br \/>\nWhen our expert group has a stock suggestion, it can pay to listen. After all, the newsletter they have actually run for over a years, <em>Motley Fool Stock Advisor<\/em>, has actually tripled the marketplace.*<\/p>\n<p>They simply exposed what they <a href=\"https:\/\/oxfordwisefinance.com\/blog\/thinking-about-buying-nvidia-stock-these-ai-stocks-might-be-better-options\/\">think are the 10 finest stocks<\/a> for financiers to purchase today&#8230; and Ventyx Biosciences wasn&#8217;t among them! That&#8217;s right &#8212; they believe these 10 stocks are even much better purchases.<\/p>\n<p>&nbsp;<\/p>\n<p><em>Jim Halley has no position in any of the stocks pointed out. The Motley Fool has positions in and advises Merck. The Motley Fool has a disclosure policy.<\/em><\/p>\n\n<p><a href=\"https:\/\/www.fool.com\/investing\/2023\/07\/03\/why-shares-of-ventyx-biosciences-rose-monday\/?source=askdougpancakes&amp;utm_source=chromefollow&amp;utm_medium=feed&amp;utm_campaign=news\" rel=\"nofollow\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>What took place On Monday, shares of Ventyx Biosciences (NASDAQ: VTYX) closed [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":4186,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","pagelayer_contact_templates":[],"_pagelayer_content":"","iawp_total_views":1,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[142,240],"tags":[],"class_list":["post-4184","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance-business","category-stock-market","col-md-12"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Why Shares of Ventyx Biosciences Rose Monday - Blog - Oxford Wise Finance<\/title>\n<meta name=\"description\" content=\"The company has several promising autoimmune therapies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Why Shares of Ventyx Biosciences Rose Monday - Blog - Oxford Wise Finance\" \/>\n<meta property=\"og:description\" content=\"The company has several promising autoimmune therapies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog - Oxford Wise Finance\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-03T22:54:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-29T17:12:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/oxfordwisefinance.com\/blog\/wp-content\/uploads\/2023\/07\/Why-Shares-of-Ventyx-Biosciences-Rose-Monday.jpg?fit=2204%2C1359&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"2204\" \/>\n\t<meta property=\"og:image:height\" content=\"1359\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"From Internet\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/why-shares-of-ventyx-biosciences-rose-monday\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/why-shares-of-ventyx-biosciences-rose-monday\\\/\"},\"author\":{\"name\":\"From Internet\",\"@id\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/#\\\/schema\\\/person\\\/350cf3e9f679af8aed2a5741b3bdeab0\"},\"headline\":\"Why Shares of Ventyx Biosciences Rose Monday\",\"datePublished\":\"2023-07-03T22:54:12+00:00\",\"dateModified\":\"2024-11-29T17:12:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/why-shares-of-ventyx-biosciences-rose-monday\\\/\"},\"wordCount\":371,\"image\":{\"@id\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/why-shares-of-ventyx-biosciences-rose-monday\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/oxfordwisefinance.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Why-Shares-of-Ventyx-Biosciences-Rose-Monday.jpg?fit=2204%2C1359&ssl=1\",\"articleSection\":[\"Finance &amp; Business\",\"Stock Market\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/why-shares-of-ventyx-biosciences-rose-monday\\\/\",\"url\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/why-shares-of-ventyx-biosciences-rose-monday\\\/\",\"name\":\"Why Shares of Ventyx Biosciences Rose Monday - Blog - Oxford Wise Finance\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/why-shares-of-ventyx-biosciences-rose-monday\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/why-shares-of-ventyx-biosciences-rose-monday\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/oxfordwisefinance.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Why-Shares-of-Ventyx-Biosciences-Rose-Monday.jpg?fit=2204%2C1359&ssl=1\",\"datePublished\":\"2023-07-03T22:54:12+00:00\",\"dateModified\":\"2024-11-29T17:12:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/#\\\/schema\\\/person\\\/350cf3e9f679af8aed2a5741b3bdeab0\"},\"description\":\"The company has several promising autoimmune therapies.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/why-shares-of-ventyx-biosciences-rose-monday\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/why-shares-of-ventyx-biosciences-rose-monday\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/why-shares-of-ventyx-biosciences-rose-monday\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/oxfordwisefinance.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Why-Shares-of-Ventyx-Biosciences-Rose-Monday.jpg?fit=2204%2C1359&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/oxfordwisefinance.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Why-Shares-of-Ventyx-Biosciences-Rose-Monday.jpg?fit=2204%2C1359&ssl=1\",\"width\":2204,\"height\":1359},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/why-shares-of-ventyx-biosciences-rose-monday\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Why Shares of Ventyx Biosciences Rose Monday\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/\",\"name\":\"Blog - Oxford Wise Finance\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/#\\\/schema\\\/person\\\/350cf3e9f679af8aed2a5741b3bdeab0\",\"name\":\"From Internet\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a3a3ce4498b4cb183d19a2b5deabbf634226340ee3e79c7636c07874d7e5bf3f?s=96&d=identicon&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a3a3ce4498b4cb183d19a2b5deabbf634226340ee3e79c7636c07874d7e5bf3f?s=96&d=identicon&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a3a3ce4498b4cb183d19a2b5deabbf634226340ee3e79c7636c07874d7e5bf3f?s=96&d=identicon&r=g\",\"caption\":\"From Internet\"},\"url\":\"https:\\\/\\\/oxfordwisefinance.com\\\/blog\\\/author\\\/from-internet\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Why Shares of Ventyx Biosciences Rose Monday - Blog - Oxford Wise Finance","description":"The company has several promising autoimmune therapies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/","og_locale":"en_US","og_type":"article","og_title":"Why Shares of Ventyx Biosciences Rose Monday - Blog - Oxford Wise Finance","og_description":"The company has several promising autoimmune therapies.","og_url":"https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/","og_site_name":"Blog - Oxford Wise Finance","article_published_time":"2023-07-03T22:54:12+00:00","article_modified_time":"2024-11-29T17:12:31+00:00","og_image":[{"width":2204,"height":1359,"url":"https:\/\/i0.wp.com\/oxfordwisefinance.com\/blog\/wp-content\/uploads\/2023\/07\/Why-Shares-of-Ventyx-Biosciences-Rose-Monday.jpg?fit=2204%2C1359&ssl=1","type":"image\/jpeg"}],"author":"From Internet","twitter_card":"summary_large_image","twitter_misc":{"Written by":false,"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/#article","isPartOf":{"@id":"https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/"},"author":{"name":"From Internet","@id":"https:\/\/oxfordwisefinance.com\/blog\/#\/schema\/person\/350cf3e9f679af8aed2a5741b3bdeab0"},"headline":"Why Shares of Ventyx Biosciences Rose Monday","datePublished":"2023-07-03T22:54:12+00:00","dateModified":"2024-11-29T17:12:31+00:00","mainEntityOfPage":{"@id":"https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/"},"wordCount":371,"image":{"@id":"https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/oxfordwisefinance.com\/blog\/wp-content\/uploads\/2023\/07\/Why-Shares-of-Ventyx-Biosciences-Rose-Monday.jpg?fit=2204%2C1359&ssl=1","articleSection":["Finance &amp; Business","Stock Market"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/","url":"https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/","name":"Why Shares of Ventyx Biosciences Rose Monday - Blog - Oxford Wise Finance","isPartOf":{"@id":"https:\/\/oxfordwisefinance.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/#primaryimage"},"image":{"@id":"https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/oxfordwisefinance.com\/blog\/wp-content\/uploads\/2023\/07\/Why-Shares-of-Ventyx-Biosciences-Rose-Monday.jpg?fit=2204%2C1359&ssl=1","datePublished":"2023-07-03T22:54:12+00:00","dateModified":"2024-11-29T17:12:31+00:00","author":{"@id":"https:\/\/oxfordwisefinance.com\/blog\/#\/schema\/person\/350cf3e9f679af8aed2a5741b3bdeab0"},"description":"The company has several promising autoimmune therapies.","breadcrumb":{"@id":"https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/#primaryimage","url":"https:\/\/i0.wp.com\/oxfordwisefinance.com\/blog\/wp-content\/uploads\/2023\/07\/Why-Shares-of-Ventyx-Biosciences-Rose-Monday.jpg?fit=2204%2C1359&ssl=1","contentUrl":"https:\/\/i0.wp.com\/oxfordwisefinance.com\/blog\/wp-content\/uploads\/2023\/07\/Why-Shares-of-Ventyx-Biosciences-Rose-Monday.jpg?fit=2204%2C1359&ssl=1","width":2204,"height":1359},{"@type":"BreadcrumbList","@id":"https:\/\/oxfordwisefinance.com\/blog\/why-shares-of-ventyx-biosciences-rose-monday\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/oxfordwisefinance.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Why Shares of Ventyx Biosciences Rose Monday"}]},{"@type":"WebSite","@id":"https:\/\/oxfordwisefinance.com\/blog\/#website","url":"https:\/\/oxfordwisefinance.com\/blog\/","name":"Blog - Oxford Wise Finance","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oxfordwisefinance.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/oxfordwisefinance.com\/blog\/#\/schema\/person\/350cf3e9f679af8aed2a5741b3bdeab0","name":"From Internet","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a3a3ce4498b4cb183d19a2b5deabbf634226340ee3e79c7636c07874d7e5bf3f?s=96&d=identicon&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a3a3ce4498b4cb183d19a2b5deabbf634226340ee3e79c7636c07874d7e5bf3f?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a3a3ce4498b4cb183d19a2b5deabbf634226340ee3e79c7636c07874d7e5bf3f?s=96&d=identicon&r=g","caption":"From Internet"},"url":"https:\/\/oxfordwisefinance.com\/blog\/author\/from-internet\/"}]}},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/oxfordwisefinance.com\/blog\/wp-content\/uploads\/2023\/07\/Why-Shares-of-Ventyx-Biosciences-Rose-Monday.jpg?fit=2204%2C1359&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/oxfordwisefinance.com\/blog\/wp-json\/wp\/v2\/posts\/4184","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oxfordwisefinance.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oxfordwisefinance.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oxfordwisefinance.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/oxfordwisefinance.com\/blog\/wp-json\/wp\/v2\/comments?post=4184"}],"version-history":[{"count":4,"href":"https:\/\/oxfordwisefinance.com\/blog\/wp-json\/wp\/v2\/posts\/4184\/revisions"}],"predecessor-version":[{"id":8923,"href":"https:\/\/oxfordwisefinance.com\/blog\/wp-json\/wp\/v2\/posts\/4184\/revisions\/8923"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oxfordwisefinance.com\/blog\/wp-json\/wp\/v2\/media\/4186"}],"wp:attachment":[{"href":"https:\/\/oxfordwisefinance.com\/blog\/wp-json\/wp\/v2\/media?parent=4184"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oxfordwisefinance.com\/blog\/wp-json\/wp\/v2\/categories?post=4184"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oxfordwisefinance.com\/blog\/wp-json\/wp\/v2\/tags?post=4184"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}